About RMDM Group
We build value for our stakeholders through our impeccable research credentials and the delivery of dynamic diagnostic and nutraceutical Innovations that positively disrupt the health and wellbeing industry.
RMDM Group was set up in 2017 and is founded on the principles of the pioneering work of Dr Johannes Coy and his discovery of the TKTL1 gene.
The Leadership Team
Ali Ghaidan
CEO & Founder
Dr. Johannes Coy, Ph.D
Oncology Expert and Discoverer of the TKTL1 Gene
Dr. Letizia Gulino PhD
Head of Science & Technology
Dr Joachim Stein
Advisory Board Member
Our Vision
At RMDM Group, our vision is to empower everyone to make healthier everyday choices and significantly improve their health and wellbeing. As a one-stop-shop for preventative healthcare solutions, we are dedicated to making disease prevention and management accessible and simple for all.
We achieve this by linking our pioneering diagnostics and revolutionary nutritional products with the wisdom of traditional medicine. This comprehensive approach ensures that our solutions are not just reactive but fundamentally preventative, offering a holistic path to better health.
We recognise the systemic importance of TKTL1 (Transketolase-like 1) in disease, particularly in the field of oncology. RMDM Group has built a comprehensive platform around the study and application of TKTL1 biology, allowing us to develop uniquely targeted and effective diagnostic and management solutions.
Recognising the systemic importance of TKTL1, RMDM has built a comprehensive platform around the study and application of TKTL1 biology
Diagnostics
PanTum® Detect is an advanced multi-tumour early detection (MCED) blood test that identifies cancer risk even in healthy, symptom-free individuals.
Using innovative EDIM® (Epitope Detection in Monocytes) technology, it detects key tumour biomarkers Apo10 and TKTL1 within immune cells throughout all stages of tumour development.
As part of our screening programme, PanTum® Detect is paired with confirmatory imaging for positive cases, offering a fully integrated approach to detecting benign, premalignant, and malignant tumours before they become life-threatening.
Nutrition
RMDM’s nutritional innovations are built on the metabolic principles shaped by TKTL1. One example is The Dr. Coy Principle, which focuses on a nutritional strategy through therapeutic foods designed to support patients undergoing cancer therapy.
Dr. Coy’s concept compels cancer cells to alter how they release energy. Instead of fermenting sugar to produce energy, cancer cells are forced to burn sugar and other nutrients, changing their metabolic pathway.
This approach supports and complements preventive measures. Dr. Coy’s unique blends of natural sugars not only help to optimise physical and mental health but also address the critical link between sugar and disease.
Pharma
Leveraging deep insights into TKTL1 function, RMDM is helping to develop Benfo-Oxythiamine, a pioneering drug that directly targets the cancer-fuelling enzyme TKTL1, a key player in abnormal tumour sugar metabolism.
Patented by Dr. Johannes Coy, this innovative drug works by inhibiting TKTL1 to decelerate the metabolism of cancerous cells and restore metabolic balance.
Benfo-Oxythiamine is designed to make current cancer treatments more effective and serves as the crucial third link in RMDM’s comprehensive approach.
With its translational approach and TKTL1 focus, RMDM is driving targeted medical solutions while creating a biological model for health- bridging molecular research with real-world clinical strategies.
Diagnostics
The world’s first blood test for the early detection of all cancers.
Sugars
Natural sugars that improve everyday well-being.
Pharma
Research and development of a prodrug to improve cancer treatment success rates.
With its translational approach and TKTL1 focus, RMDM is driving targeted medical solutions while creating a biological model for health- bridging molecular research with real-world clinical strategies.
Diagnostics
The world’s first blood test for the early detection of all cancers.
Sugars
Natural sugars that improve everyday well-being.
Pharma
Research and development of a prodrug to improve cancer treatment success rates.